Skip to content

Effects of Different Protocols of Physical Training on Levels of Muscle Strength and Functional Capacity

Effects of Different Protocols of Physical Training on Levels of Muscle Strength and Functional Capacity on Patients With Peripheral Artery Disease: a Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03092336
Enrollment
73
Registered
2017-03-27
Start date
2011-05-31
Completion date
2018-03-31
Last updated
2017-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease

Keywords

Peripheral Arterial Disease, training

Brief summary

Introduction: the peripheral obstructive arterial disease is an condition that affects around 15% of the world population interfering in muscle strength, life quality and functional capacity of patients.

Detailed description

Study aim: to assess three methods of physical training (strength training, aerobic training and electrical stimulation training) in muscle strength, functional capacity and life quality of patients with peripheral obstructive arterial disease

Interventions

OTHERElectrical Stimulation

electrical stimulation training

OTHERStrength training

strength training group

Sponsors

Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of PAD and IC. * Age from 40 to 80 years. * Stage I and II of Fontaine. * Symptoms of Intermittent Claudication for at least 3 months with resting brachial index ≤ 0.90 in 1 or 2 legs

Exclusion criteria

* Critical ischemia in one of the lower limbs. * Moderate or severe ulcers in one of the lower limbs. Orthopedic problems that prevent exercise or evaluation. * Participation in other studies with rehabilitation. * Decreased arterial hypertension. * Decompensated Diabetes

Design outcomes

Primary

MeasureTime frameDescription
cardiopulmonary exercise test13 monthsassess functional capacity

Secondary

MeasureTime frameDescription
WHOQOL Questionnaire13 monthsasses quality of life
Brachial ultrasonography13 monthsendothelial function
Analog scale of pain13 monthsassess pain intensity
Repetition maximum strength test (1RM)13 monthsassess Muscle strengh

Countries

Brazil

Contacts

Primary ContactMárcio Garcia, MD
mgmarciogarcia@gmail.com05551597634
Backup ContactRosane M Nery, PhD
rosane.nery@gmail.com0555133597634

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026